Vyne Therapeutics Inc
NASDAQ:VYNE

Watchlist Manager
Vyne Therapeutics Inc Logo
Vyne Therapeutics Inc
NASDAQ:VYNE
Watchlist
Price: 0.5648 USD -2.62% Market Closed
Market Cap: 18.8m USD

During the last 3 months Vyne Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 57% over this period (open performance analysis).

The last transaction was made on Jan 15, 2025 by Lepore Patrick G , who bought 43.8k USD worth of VYNE shares.

Last Transactions:
Lepore Patrick G
$+43.8k
Lepore Patrick G
$+50.8k
Harsch Mutya
$+25k
Lepore Patrick G
$+49.7k
Lepore Patrick G
$+705
Lepore Patrick G
$+1.1k
Edelman Joseph
$-24.2k
Edelman Joseph
$-25.6k
Edelman Joseph
$-42k
Lepore Patrick G
$+2.5k
Edelman Joseph
$-203.9k
Lepore Patrick G
$+5.1k
Perceptive Advisors Llc
$+138.9k
Lepore Patrick G
$+1.2k
Saik Andrew
$+812.9
Domzalski David
$+1.4k
Edelman Joseph
$+69.4k
Sohail Faysal A.
$-51.8k
Venbio Global Strategic Fund Ii L.p.
$+62.6k
Remeditex Ventures Llc
$+23.6k
Vivo Capital Viii, Llc
$+61k
Cha Albert
$+61k
View All Transactions

During the last 3 months Vyne Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 57% over this period (open performance analysis).

The last transaction was made on Jan 15, 2025 by Lepore Patrick G , who bought 43.8k USD worth of VYNE shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
1
43.8k USD

Vyne Therapeutics Inc
Insider Trading Chart

Vyne Therapeutics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Vyne Therapeutics Inc
Last Insider Transactions

Global
Insiders Monitor

Vyne Therapeutics Inc
Glance View

Market Cap
17.9m USD
Industry
Pharmaceuticals

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. The company is headquartered in Bridgewater, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-01-25. The firm is engaged in developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions and rare skin diseases with high unmet medical need. The Company’s proprietary pipeline FMX114, which is a potential treatment of mild-to-moderate atopic dermatitis in patients 12 years of age and older, and access to a library of bromodomain and extra-terminal (BET) domain inhibitors in both topical and oral forms for the potential treatment of major immuno-inflammatory conditions and rare skin diseases.

VYNE Intrinsic Value
0.0413 USD
Overvaluation 93%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top